Intellego Technologies (INT) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
2 Feb, 2026Background and investigation
Following the arrest of the former CEO for gross fraud in November 2025, trading was halted, an interim CEO was appointed, and SEK 100 million was seized.
KPMG was engaged to conduct an independent forensic investigation into financial reporting and market communication for 2025, analyzing over 600 GB of data, including accounting records, emails, and interviews.
The investigation focused on SEK 640 million of reported revenue from eight large purchase orders, covering Q1–Q3 2025 and the period 1 January–31 October 2025.
The scope covered only 2025 transactions for Intellego Technologies AB, with an expanded review of earlier years ongoing.
Nasdaq raised concerns about transparency, revenue recognition, and communication, prompting a regulatory review.
Key findings and conclusions
SEK 640 million in reported revenue for 2025 was materially incorrect, misleading, and should not have been recognized.
No evidence was found of actual collaboration, binding agreements, or product deliveries for the eight major purchase orders; only MoveoMed called off a minor delivery, which was not fulfilled.
Partnerships with customers were forward-looking and represented potential future revenue, not current sales.
Nearly 99% of reported revenue from January to September 2025 originated from these questionable purchase orders.
Communicated financial information, including quarterly reports and press releases, was materially misleading.
Identified activities and irregularities
Multiple versions of the eight purchase orders were produced: one set for customer negotiations and another, altered version for invoicing and revenue recognition.
Altered versions of purchase orders were provided to the accounting firm, omitting critical terms to justify revenue recognition.
The former CEO was solely responsible for instructing the accounting firm, manipulating documents, and using large purchase orders to influence market perception and attract investors.
Invoices were created in the accounting system but sent only to the CEO, not customers; customers were unaware of the orders.
Purchase orders were open-ended, unsigned, or lacked binding obligations, making revenue recognition unjustified.
Latest events from Intellego Technologies
- Massive fraud led to SEK 774m in reversed revenues; Daro drives growth amid legal and liquidity risks.INT
Q4 202520 Feb 2026 - Q3 sales up 295% and EBIT margin at 58%, with strong global disinfection demand.INT
Q3 202510 Nov 2025 - Strong Q2 growth, robust cash, and expanding global partnerships drive positive outlook.INT
Investor Update22 Sep 2025 - Q2 2025 saw record sales and profit, with 2025 targets raised amid accelerating global growth.INT
Q2 202527 Aug 2025 - Q3 revenue up 71% year-over-year; major projects and partnerships to drive future growth.INT
Q3 202413 Jun 2025 - Record sales, profit, and cash flow in H1 2024, with strong outlook and ongoing expansion.INT
Q2 202413 Jun 2025 - Record Q1 growth and raised 2025 targets highlight Intellego's accelerating momentum.INT
Q1 20256 Jun 2025 - Strong 2024 growth, robust liquidity, and major partnerships position Intellego for 2025 expansion.INT
Q4 20245 Jun 2025